Dyne Therapeutics (DYN) Change in Acquisitions & Divestments (2021 - 2026)

Dyne Therapeutics (DYN) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $28.6 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 864.58% year-over-year to $28.6 million in Q1 2026; TTM through Mar 2026 was $43.5 million, a 221.65% increase from a year earlier, with the FY2025 full-year figure at $17.9 million, up 69.0% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $28.6 million, up from $9.4 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for DYN reached as high as $28.6 million in Q1 2026 and fell as low as $1000.0 in Q3 2025.
• Historically, Change in Acquisitions & Divestments has averaged $5.6 million across 5 years, with a median of $2.5 million in 2022.
• Across the five-year window, Change in Acquisitions & Divestments sank 99.94% in 2025 and soared 864.58% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $395000.0 in 2022, then jumped by 363.04% to $1.8 million in 2023, then surged by 381.9% to $8.8 million in 2024, then rose by 6.44% to $9.4 million in 2025, then surged by 205.35% to $28.6 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $28.6 million in Q1 2026, $9.4 million in Q4 2025, and $1000.0 in Q3 2025.